Blueprint Medicines Corpo... (BPMC)
NASDAQ: BPMC
· Real-Time Price · USD
98.99
9.49 (10.60%)
At close: May 01, 2025, 2:49 PM
Blueprint Medicines Revenue
Blueprint Medicines reported an annual revenue of $508.82M, reflecting a 104.04% growth. For the quarter ending December 31, 2024, Blueprint Medicines generated $146.37M in revenue.
Revenue (ttm)
$508.82M
Revenue Growth
104.04%
Price / Sales Ratio
10.77
Revenue / Employee
$784.01K
Employees
649
Market Cap
6.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 508.82M | +104.04% |
| Dec 31, 2023 | 249.38M | +22.22% |
| Dec 31, 2022 | 204.04M | +13.30% |
| Dec 31, 2021 | 180.08M | -77.31% |
| Dec 31, 2020 | 793.74M | n/a |